BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20036889)

  • 21. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis.
    Fujiwaki R; Hata K; Iida K; Maede Y; Miyazaki K
    Anticancer Res; 2000; 20(2B):1317-22. PubMed ID: 10810442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis.
    Wang Z; Chen Y; Li X; Xu L; Ma W; Chang L; Ju F
    Asian Pac J Cancer Prev; 2012; 13(1):27-31. PubMed ID: 22502683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer.
    Jach R; Dyduch G; Radon-Pokracka M; Przybylska P; Mika M; Dulinska-Litewka J; Zajac K; Huras H; Streb J; Stangel-Wojcikiewicz K; Dziadek O; Galarowicz B
    Neuro Endocrinol Lett; 2011; 32(4):530-9. PubMed ID: 21876509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.
    Pajares MJ; Agorreta J; Larrayoz M; Vesin A; Ezponda T; Zudaire I; Torre W; Lozano MD; Brambilla E; Brambilla C; Wistuba II; Behrens C; Timsit JF; Pio R; Field JK; Montuenga LM
    J Clin Oncol; 2012 Apr; 30(10):1129-36. PubMed ID: 22355056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.
    O-charoenrat P; Rhys-Evans P; Eccles SA
    Cancer; 2001 Aug; 92(3):556-68. PubMed ID: 11505400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma.
    Shintani S; Li C; Ishikawa T; Mihara M; Nakashiro K; Hamakawa H
    Oral Oncol; 2004 Jan; 40(1):13-20. PubMed ID: 14662410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers.
    Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
    Br J Cancer; 1999 May; 80(5-6):827-33. PubMed ID: 10360662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
    Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
    Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas.
    Yoshinaga K; Ito K; Moriya T; Nagase S; Takano T; Niikura H; Sasano H; Yaegashi N; Sato Y
    Cancer Sci; 2011 Feb; 102(2):446-51. PubMed ID: 21175993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer.
    Matsui T; Shigeta T; Umeda M; Komori T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):436-42. PubMed ID: 26216169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C.
    Moussai D; Mitsui H; Pettersen JS; Pierson KC; Shah KR; Suárez-Fariñas M; Cardinale IR; Bluth MJ; Krueger JG; Carucci JA
    J Invest Dermatol; 2011 Jan; 131(1):229-36. PubMed ID: 20827282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of vascular endothelial growth factor receptors during male germ cell differentiation in the mouse.
    Nalbandian A; Dettin L; Dym M; Ravindranath N
    Biol Reprod; 2003 Sep; 69(3):985-94. PubMed ID: 12773425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
    Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
    Tokuyama W; Mikami T; Masuzawa M; Okayasu I
    Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells.
    Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K
    Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma.
    Yu H; Zhang S; Zhang R; Zhang L
    J Exp Clin Cancer Res; 2009 Jul; 28(1):98. PubMed ID: 19589137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas.
    Ueda M; Terai Y; Yamashita Y; Kumagai K; Ueki K; Yamaguchi H; Akise D; Hung YC; Ueki M
    Int J Cancer; 2002 Mar; 98(3):335-43. PubMed ID: 11920583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
    Wang Z; Lv J; Zhang T
    Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of tissue expression and serum contents of VEGF-C in cervical diseases of Uighur women].
    Wang XL; Zhang YY; Gu ZA; Zhu MY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):60-2. PubMed ID: 22919758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.